-
Founded in:
1990-05-11 -
Country:
China -
Address:
No. 6, Jinhai East Road, Sanzao, Jinwan District, Zhuhai City -
Tax NO.:
91440400192522224J -
Registered Funds:
50 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tosufloxacin tosilate |
This product is a broad-spectrum quinolone antibacterial drug that achieves antibacterial or bactericidal effects by inhibiting bacterial DNA gyrase. It has antibacterial effects on the following bacteria in vitro: Gram-positive bacteria (such as pneumococcus, Streptococcus pyogenes, etc.), Gram-negative bacteria (such as Enterobacteriaceae, Pseudomonas aeruginosa, etc.), other Gram-negative bacteria (such as Neisseria gonorrhoeae, Haemophilus influenzae, etc.) and anaerobic bacteria (such as Peptostreptococcus, Propionibacterium acnes, etc.).
More
This product is a broad-spectrum quinolone antibacterial drug that achieves antibacterial or bactericidal effects by inhibiting bacterial DNA gyrase. It has antibacterial effects on the following bacteria in vitro: Gram-positive bacteria (such as pneumococcus, Streptococcus pyogenes, etc.), Gram-negative bacteria (such as Enterobacteriaceae, Pseudomonas aeruginosa, etc.), other Gram-negative bacteria (such as Neisseria gonorrhoeae, Haemophilus influenzae, etc.) and anaerobic bacteria (such as Peptostreptococcus, Propionibacterium acnes, etc.). |
107097-79-0 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tosufloxacin tosilate |
Quinolones are broad-spectrum antibacterial drugs that inhibit bacterial DNA gyrase to achieve bacteriostatic or bactericidal effects. They are effective against Gram-positive bacteria, Gram-negative bacteria, and some anaerobic bacteria.
More
Quinolones are broad-spectrum antibacterial drugs that inhibit bacterial DNA gyrase to achieve bacteriostatic or bactericidal effects. They are effective against Gram-positive bacteria, Gram-negative bacteria, and some anaerobic bacteria. |
107097-79-0 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tosufloxacin tosilate |
Quinolone is a broad-spectrum antibiotic that has antibacterial effects in vitro against Gram-positive bacteria (such as Pneumococcus, Streptococcus pyogenes, etc.), Gram-negative bacteria (such as Enterobacteriaceae, Pseudomonas aeruginosa, etc.), other Gram-negative bacteria (such as Neisseria gonorrhoeae, Haemophilus influenzae, etc.) and anaerobic bacteria (such as Streptococcus, Propionibacterium acnes, etc.), and achieves antibacterial or bactericidal effects by inhibiting bacterial DNA gyrase.
More
Quinolone is a broad-spectrum antibiotic that has antibacterial effects in vitro against Gram-positive bacteria (such as Pneumococcus, Streptococcus pyogenes, etc.), Gram-negative bacteria (such as Enterobacteriaceae, Pseudomonas aeruginosa, etc.), other Gram-negative bacteria (such as Neisseria gonorrhoeae, Haemophilus influenzae, etc.) and anaerobic bacteria (such as Streptococcus, Propionibacterium acnes, etc.), and achieves antibacterial or bactericidal effects by inhibiting bacterial DNA gyrase. |
107097-79-0 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| D-fructose 1,6-bis(dihydrogen phosphate) |
Dextrorotatory fructose 1,6-diphosphate (FDP) is an intermediate product of glycolysis. It regulates several enzymatic reactions in cells by activating phosphofructokinase, pyruvate kinase and lactate dehydrogenase. FDP can act on cell membranes, promote the cell's uptake of circulating potassium and stimulate the production of high-energy phosphate and 2,3-diphosphoglycerol in cells. In addition, FDP can reduce hemolysis of erythrocytes caused by mechanical trauma and inhibit the production of oxygen free radicals caused by chemical stimulation. In COPD patients, FDP is beneficial for treatment, especially for strengthening respiratory intensity, which is manifested as an increase in PImax, PaO2 and tolerance.
More
Dextrorotatory fructose 1,6-diphosphate (FDP) is an intermediate product of glycolysis. It regulates several enzymatic reactions in cells by activating phosphofructokinase, pyruvate kinase and lactate dehydrogenase. FDP can act on cell membranes, promote the cell's uptake of circulating potassium and stimulate the production of high-energy phosphate and 2,3-diphosphoglycerol in cells. In addition, FDP can reduce hemolysis of erythrocytes caused by mechanical trauma and inhibit the production of oxygen free radicals caused by chemical stimulation. In COPD patients, FDP is beneficial for treatment, especially for strengthening respiratory intensity, which is manifested as an increase in PImax, PaO2 and tolerance. |
488-69-7 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dequalinium chloride |
This product is a cationic surfactant with a broad-spectrum antibacterial effect and is effective against common pathogenic bacteria and fungal infections in the oral cavity and throat.
More
This product is a cationic surfactant with a broad-spectrum antibacterial effect and is effective against common pathogenic bacteria and fungal infections in the oral cavity and throat. |
522-51-0 | 7 |